Development of the metabolic syndrome has been identified as a significant risk factor for future adult health. Metabolic syndrome components (obesity, insulin and glucose insensitivity and hypertension) have been identified in offspring derived from a range of different maternal gestational nutritional challenges
[32]. The period in development during which offspring growth, metabolic and cardiovascular physiology displays maximal susceptibility to programming is widely debated. Gestational LPD in the rodent programs changes in offspring growth which perpetuate into adult life
[33],
[34]. Interestingly, feeding these offspring hypercaloric or high fat diets postnatally
[35], or the suckling of rat pups from lean mothers by obese dams
[36], subsequently programs offspring obesity, hypertension, insulin resistance and serum leptin and glucose levels, highlighting the sensitivity of the early perinatal period. However, our current study is, to our knowledge, the first to demonstrate that maternal periconceptional protein undernutrition in the mouse programmes growth, SBP and adiposity homeostasis in aging offspring.
This study aimed to determine whether altered adult phenotypes evident at 6 months, induced through maternal periconceptional diet
[25],
[26], persisted into aging mice. Our first major observation was that the enhanced growth phenotype in Emb-LPD females at 6 months was maintained until 1 year of age despite a smaller sample size. Interestingly, by 1 year, LPD females had become lighter than NPD females, a phenotype not observed at 6 months. Analysis of individual correlates revealed that weight at 3 weeks of age was still a significant predictor of adult weight at 1 year for Emb-LPD offspring. We also observed significant positive interactions of adiposity (combined fat pad weight) with weight at 1 year in all treatment groups. These findings demonstrate how early life factors (such as size and weight) can be more predictive of, and associate strongly with, adult disease susceptibility, a central concept of the Developmental Origins of Health and Disease (DOHaD) hypothesis
[37].
To gain further mechanistic insights into the changes in body weight observed, we assessed whole body adiposity and gene expression profiles in white (retroperitoneal; WAT) and brown adipose tissue (interscapular; IBAT). Whilst LPD females had significantly reduced inguinal and retroperitoneal fat pad weights, no significant changes were observed in Emb-LPD female adiposity when compared to NPD females. Analysis of gene expression patterns revealed Emb-LPD females had elevated
Insr and
Igf1r expression in WAT, but reduced IBAT
Ucp1 expression. In contrast, LPD females displayed increased IBAT
Ucp1 expression. LPD females also displayed strong positive associations of insulin and glucose levels with IBAT
Ucp1 and
Adrb3 expression, whilst negative associations with WAT
Insr and
Igf1r expression. WAT has a predominant role in energy storage in the form of triacylglycerol. Stimulation of the insulin (
Insr) and IGF-1 (
Igf1r) receptors induces glucose transporter translocation, increasing intracellular glucose levels. In contrast, adrenergic signalling, through the β3-adrenoceptor (
Adrb3) in IBAT upregulates expression of inner mitochondrial membrane UCP-1
[38], uncoupling the proton electrochemical gradient and liberating heat
[39]. Elevated IBAT
Ucp1 in LPD females, in addition with serum metabolite (glucose and insulin) correlations (positive IBAT
Ucp1 and
Adrb3, negative WAT
Insr and
Igf1r) are suggestive of an energy liberating phenotype. In contrast, elevated WAT
Insr and
Igf1r expression coupled with reduced IBAT
Ucp1 expression in Emb-LPD females is suggestive of an energy storage phenotype. Nutritional programming of offspring adipose gene expression has been reported. In the rat, manipulation of maternal diet during gestation has been shown to alter adipose carbohydrate, lipid, and protein metabolism gene expression patterns
[8], alter WAT expression profiles to resemble that of IBAT
[39] and upregulate mRNA expression of angiotensinogen and adiponectin
[40].
The DOHaD hypothesis proposes that offspring metabolic homeostatic levels are set during fetal development in direct response to maternal nutritional cues. However, subsequent mismatch between predicted and actual nutritional levels increases adult disease risk
[37]. Previously
[26], we speculated that in response to the significant changes in maternal nutritional environment following Emb-LPD
[30], the preimplantation embryo initiates mechanisms to enhance nutrient retrieval and maintain growth. However, the subsequent mismatch between pre- and postimplantation nutrition results in these adaptations becoming maladaptive, driving enhanced fetal and postnatal growth and adult hypertension. Our current findings, that Emb-LPD females appear to up-regulate energy storing and down-regulate energy-utilising pathways in adipose tissue, suggest that an enhanced nutrient retrieval/storage phenotype is still evident at 1 year, and still associates with hypertension. Interestingly, LPD females displayed an opposite adipose phenotype, suggestive of increased energy utilisation and reduced adiposity. It therefore seems that embryonic adaptations made in response to preimplantation LPD were appropriate for the remainder of gestation, preventing excessive fetal and perinatal growth, but become maladaptive during later adult life, programming enhanced energy utilisation, significant weight and adiposity loss as well as hypertension.
Adipose tissue and the adipokines it secrets also has a role in the development of cardiovascular disease. Factors such as angiotensinogen, adiponectin, leptin, angiotensin-converting enzyme and plasminogen activator inhibitor-1 (PAI-1) are all secreted from adipose tissue and have been implicated in the development of cardiovascular disease in the offspring
[41]. However, whilst no direct correlation between fat pad weight and adult SBP was observed for any group, potential influences of such factors on offspring cardiovascular regulation cannot be ruled out. Alternatively, additional factors may also have influenced SBP regulation. Previously, we demonstrated that resistance arteries from male Egg-LDP, LPD and Emb-LPD groups displayed impaired endothelial-dependent and independent vasodilatation and elevated angiotensin-converting enzyme activity
[25],
[26]. Similar impairments in vascular dynamics and cardiac function have been observed in offspring from rat dams fed LPD throughout gestation
[14],
[42] and sheep exposed to maternal undernutrition during pre- and periconceptional periods
[43]. Studies have also revealed impairments in nephrogenesis in rat offspring from LPD dams programming hypertension
[44], whilst aortic stiffness, reduced vascular smooth muscle cell number, endothelial dysfunction and decreased kidney Na
+-K
+-ATPase activity have been reported following maternal over nutrition
[45]. Additional investigations would be necessary for identifying the mechanisms involved in the elevated SBP observed within the present study.
Offspring glucose and insulin homeostasis appear equally sensitive to maternal gestational nutrition. Both over- and under-nutrition result in offspring hyperphagia, adiposity and insulin resistance
[46],
[47], and appear age and sex dependent. As offspring age, initial insulin sensitivity is replaced with insulin resistance in later adulthood
[47],
[48]. In rats, 20 week old male offspring from LPD dams were found to be insulin resistant and hyperinsulinemic whilst female offspring of the same age were not
[49]. Similarly, Ozanne et al., showed that fifteen month old males from LPD rat dams displayed impaired glucose tolerance whilst females displayed similar insulin level results to controls in glucose tolerance tests
[50]. However, no significant differences in offspring serum glucose or insulin levels were observed between any treatment groups. As with our SBP data, additional studies into glucose/insulin tolerance as well as pancreatic structure and function would be necessary to fully determine offspring homeostatic capacity.
As these and our own data highlight, sex specific phenotypic responses are often observed following maternal dietary manipulation. Female offspring from mice fed high-fat diets prior to gestation become hypertensive and hypercholesterolemic and have reduced locomotor activity
[51] but not males. In the rat, the use of maternal LPD exclusively during the preimplantation period elevated systolic blood pressure only in male offspring
[30], whilst a maternal low-sodium diet reduced fetal growth and increased blood pressure only in females
[52]. One explanation for the sex specific effects could be the differences in sex hormones which may influence fetal/postnatal development affecting adult disease risk. The progression of renal injury has been linked to androgen levels in males
[53] whilst a protective role has been shown for estrogen
[54]. Recently, studies have also identified sex specific patterns of gene expression in human placentas
[55] as well as those collected from mouse dams fed diets of differing fat content
[56]. In addition, differences between the stages exposed within the current study (post fertilisation development versus gamete maturation), and as such potential influence of the presence (post-fertilisation) or absence (pre-fertilisation) of the paternal genome during the dietary manipulation period could also differentially affect fetal and postnatal development.
In conclusion, our results are the first to demonstrate the effects of maternal periconceptional nutrition on adult body weight, cardiovascular physiology and adiposity regulation in aging animals. Our findings reveal subtle but significant differences in central regulatory processes influencing adult body weight and adipose tissue development and function dependent upon the duration and stage in development during which maternal nutrition is manipulated. Whilst the evidence from human and other animal model studies support the premise that early sub-optimal environmental conditions can alter adult physiology and disease risk, the mechanisms underlying these long-term alterations are not yet fully understood. Further research is therefore essential for the identification of fundamental factors important for prevention of metabolic diseases in adulthood.